Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer

被引：4
|
作者：
Rodriguez, Cesar A. [1 ]
Martin, Teresa [1 ]
Lozano, Rebeca [1 ]
Gomez, Amalia [1 ]
Cruz, Juan J. [1 ]
机构：
[1] Hosp Univ Salamanca IBSAL, Dept Med Oncol, Salamanca, Spain
来源：
BREAST JOURNAL | 2017年 / 23卷 / 06期
关键词：
bevacizumab; breast cancer; nasal septum perforation; SEPTUM PERFORATION; PACLITAXEL; THERAPY; TRIAL;
D O I：
10.1111/tbj.12913
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Nasal septum perforation in patients with cancer receiving systemic therapy is rare, and its association with bevacizumab use has described recently in the literature. Here, we report the case of a 34-year-old woman with hormone-sensitive, HER-2/neu negative, metastatic breast cancer who develope a nasal septum perforation during the treatment with paclitaxel and bevacizumab.
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
  • [41] Small bowel perforation in a patient with metastatic renal cancer treated with radiotherapy and Sunitinib
    Kwan, Amy
    McGrath, Sophie
    Falconer, Alison
    Cohen, Patrizia
    Buchanan, Gordon
    Christmas, Tim
    Savage, Philip
    JOURNAL OF CLINICAL UROLOGY, 2010, 3 (06) : 253 - 255
  • [42] Bevacizumab in the Treatment of Metastatic Breast Cancer Bevacizumab in Breast Cancer: The Best Is Yet to Come?
    Traina, Tiffany A.
    ONCOLOGY-NEW YORK, 2009, 23 (04): : 327 - 332
  • [43] Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis
    Di Salvatore, M.
    Lo Giudice, L.
    Rossi, E.
    Santonocito, C.
    Nazzicone, G.
    Rodriquenz, M. G.
    Cappuccio, S.
    Inno, A.
    Fuso, P.
    Orlandi, A.
    Strippoli, A.
    Capoluongo, E.
    Astone, A.
    Cassano, A.
    Barone, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (01): : 40 - 46
  • [44] Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis
    M. Di Salvatore
    L. Lo Giudice
    E. Rossi
    C. Santonocito
    G. Nazzicone
    M. G. Rodriquenz
    S. Cappuccio
    A. Inno
    P. Fuso
    A. Orlandi
    A. Strippoli
    E. Capoluongo
    A. Astone
    A. Cassano
    C. Barone
    Clinical and Translational Oncology, 2016, 18 : 40 - 46
  • [45] Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival
    Paiva, Tadeu Ferreira, Jr.
    Fonseca de Jesus, Victor Hugo
    Marques, Raul Amorim
    Balieiro Anastacio da Costa, Alexandre Andre
    de Macedo, Mariana Petaccia
    Peresi, Patricia Maria
    Damascena, Aline
    Rossi, Benedito Mauro
    Begnami, Maria Dirlei
    Cordeiro de Lima, Vladmir Claudio
    BMC CANCER, 2015, 15
  • [46] Speckle-Tracking Echocardiography for Cardioncological Evaluation in Bevacizumab-Treated Colorectal Cancer Patients
    Sonaglioni, Andrea
    Albini, Adriana
    Fossile, Emanuela
    Pessi, Maria Adelaide
    Nicolosi, Gian Luigi
    Lombardo, Michele
    Anza, Claudio
    Ambrosio, Giuseppe
    CARDIOVASCULAR TOXICOLOGY, 2020, 20 (06) : 581 - 592
  • [47] Speckle-Tracking Echocardiography for Cardioncological Evaluation in Bevacizumab-Treated Colorectal Cancer Patients
    Andrea Sonaglioni
    Adriana Albini
    Emanuela Fossile
    Maria Adelaide Pessi
    Gian Luigi Nicolosi
    Michele Lombardo
    Claudio Anzà
    Giuseppe Ambrosio
    Cardiovascular Toxicology, 2020, 20 : 581 - 592
  • [48] Pyopneumothorax during bevacizumab-containing chemotherapy in a patient with metastatic breast cancer
    Noriko Goda
    Yoshiharu Kawabuchi
    Masanobu Watari
    Takashi Kumada
    Tomohiro Kondo
    Satoshi Inoue
    Takuro Yamaguchi
    Yuta Kuroo
    Atsushi Nakamitsu
    International Cancer Conference Journal, 2016, 5 (1) : 40 - 44
  • [49] Pyopneumothorax during bevacizumab-containing chemotherapy in a patient with metastatic breast cancer
    Goda, Noriko
    Kawabuchi, Yoshiharu
    Watari, Masanobu
    Kumada, Takashi
    Kondo, Tomohiro
    Inoue, Satoshi
    Yamaguchi, Takuro
    Kuroo, Yuta
    Nakamitsu, Atsushi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2016, 5 (01): : 40 - 44
  • [50] RANDOMISED PHASE III STUDY OF BEVACIZUMAB plus CHEMOTHERAPY BEYOND PROGRESSION IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER: TML STUDY KRAS SUBGROUP FINDINGS
    Van Cutsem, Eric
    Maria Vieitez, Jose
    Bouche, Olivier
    Osterlund, Pia
    Bennouna, Jaafar
    Andre, Thierry
    Sastre, Javier
    Alonso-Orduna, Vicente
    Kubicka, Stefan
    Greil, Richard
    von Moos, Roger
    Reyes-Rivera, Irmarie
    Scherer, Stefan
    Bendahmane, Belguendouz
    Arnold, Dirk
    ANNALS OF ONCOLOGY, 2012, 23 : 15 - 15
12345